The Motley Fool Investing Philosophy: We generally recommend investors buy shares of at least 25 stocks and hold them for at least 5 years. Learn More
| 1 Year | 5 Year | 5 Year Annualized | Since IPO | |
|---|---|---|---|---|
| CNC | -34.4% | -34.68% | -8.16% | +2,583% |
| S&P | +13.95% | +78.35% | +12.25% | +519% |
Centene Corp. operates as a healthcare enterprise, which engages in the provision of programs and services to government sponsored healthcare programs. It operates through the following segments: Medicaid, Medicare, Commercial, and Other. The company was founded in 1984 and is headquartered in St. Louis, MO.
This healthcare stock has struggled this year, but things are suddenly looking up.
| Q4 2025 | YOY Change | |
|---|---|---|
| Revenue | $49.73B | 21.9% |
| Market Cap | $20.23B | -33.9% |
| Market Cap / Employee | $334.31K | 0.0% |
| Employees | 60.5K | 0.0% |
| Net Income | -$1,100,000.00K | -492.9% |
Currently no data to display
Currently no data to display.
Currently no data to display.
| Q4 2025 | YOY Change | |
|---|---|---|
| Net Cash | $17.89B | 27.2% |
| Q4 2025 | YOY Change | |
|---|---|---|
| Long Term Debt | $17.35B | -9.4% |
| Short Term Debt | $50.00M | -81.3% |
| Q4 2025 | YOY Change | |
|---|---|---|
| Return On Assets | -8.33% | -12.2% |
| Return On Invested Capital | 4.58% | 0.5% |
| Q4 2025 | YOY Change | |
|---|---|---|
| Free Cash Flow | $224.00M | 130.2% |
| Operating Free Cash Flow | $437.00M | 174.4% |
| Metric | Q3 2024 | Q4 2024 | Q1 2025 | Q2 2025 | YoY Change |
|---|---|---|---|---|---|
| Price to Earnings | 13.06 | 9.70 | 9.04 | 13.42 | 6.69% |
| Price to Book | 1.14 | 0.97 | 0.64 | 0.97 | -14.70% |
| Price to Sales | 0.18 | 0.15 | 0.09 | 0.10 | -44.31% |
| Price to Tangible Book Value | 8.74 | 5.27 | 3.62 | 3.83 | -48.29% |
| Price to Free Cash Flow TTM | 20.27 | 24.81 | 5.22 | 4.68 | -97.09% |
| Free Cash Flow Yield | 4.9% | 4.0% | 19.2% | 21.4% | 3336.58% |
| Return on Equity | 12.6% | 7.5% | -21.9% | -28.8% | -327.58% |
| Total Debt | $18.32B | $17.58B | $17.58B | $17.40B | -10.44% |
No podcast episodes available.
Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.
